Health Trials

A Multicenter Cancer Biospecimen Collection Study

ConditionsCancer of Head and NeckLung Cancer, Nonsmall CellSmall-cell Lung CancerUrothelial CarcinomaGastroesophageal Junction AdenocarcinomaCervical CancerEsophageal Squamous Cell CarcinomaTriple Negative Breast CancerHepatocellular CarcinomaRenal Cell CarcinomaColorectal Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCofactor Genomics, Inc.

About this trial

This study will collect de-identified tumor samples, with correlated clinical/demographic data and tissue histology, from patients selected or scheduled for pre-treatment tumor biopsy or who have had a recent pre-treatment tumor biopsy. These specimens and clinical data may be used in subsequent studies for the development and validation of a diagnostic test.

Eligibility criteria

Qualifiers

head and neck squamous cell carcinoma (HNSCC)

non-small-cell lung cancer (NSCLC)

small cell lung cancer (SCLC)

urothelial carcinoma (UCC)

Disqualifiers

Inability or unwillingness to provide informed consent.

Subject who does/did not have one of the cancers listed above (other histologies).

Subject has already participated in this trial.

Trial design

Treatments tested in this trial

  • OncoPrism™ assay

Treatment groups

1,650 Participants
are divided into 11 treatment groups

11

Treatment groups

See each treatment group below.

Sponsors and collaborators

Cofactor Genomics, Inc.

Lead sponsor

Curebase Inc.

Collaborator

Source ClinicalTrials.gov